Benzinga's Top Pre-Market NASDAQ Gainers (VVUS, OREX, CIGX, TEVA)

VIVUS Inc VVUS shares surged 15.69% to $7.30 in the pre-market session. VVUS reported that its weight loss drug Qnexa helped lowering blood pressure levels. Orexigen Therapeutics Inc OREX shares advanced 6.94% to $3.08 in the pre-market session. OREX presented additional Contrave data from Phase 3 COR-II trial. Star Scientific Inc CIGX climbed 3.52% to $5 in the pre-market session. CIGX shares have jumped 70.67% over the past 52 weeks, while the S&P 500 index has gained 12.21% in the same period. Teva Pharmaceutical Industries Ltd TEVA jumped 1.44% to $51.27 in the pre-market session. TEVA's PEG ratio is 0.98. Read more from Benzinga's Markets.